How are MSCs thought to work? The paracrine hypothesis
Current thinking is that MSCs act mainly by secreting signalling molecules that change the local environment, not by turning into replacement tissue.

Key takeaways.
- The paracrine hypothesis holds that MSCs act mainly through secreted molecules, not by becoming new tissue.
- The secretome is everything MSCs secrete: cytokines, growth factors and extracellular vesicles.
- Immunomodulation, the adjustment of immune cell behaviour, is described as a core MSC mechanism.
- Inflammatory licensing means MSCs need inflammatory signals such as IFN-gamma and TNF-alpha to become active.
- In neurological research, evidence suggests MSCs do not efficiently become neurons.
- Mechanism is not proof of benefit. These therapies are not FDA-approved for the uses clinics market.
From replacement to signalling
Early assumptions held that transplanted cells would directly replace damaged tissue. That view has given way to a different one.
The paracrine hypothesis proposes that mesenchymal stem/stromal cells (MSCs) exert their biological effects mainly by secreting bioactive molecules that modulate the local environment. Direct differentiation into replacement tissue cells is not thought to be the main mechanism.
The secretome
The secretome is the complete collection of bioactive molecules that MSCs secrete. It includes cytokines, growth factors and extracellular vesicles. Under the paracrine hypothesis, these secreted factors carry the biological effects seen in research.
Immunomodulation and inflammatory licensing
Immunomodulation means changing how immune cells behave. In the research described in the course, MSCs shift macrophages from a pro-inflammatory M1 phenotype to an anti-inflammatory M2 phenotype. They also suppress T-cell proliferation and promote regulatory T-cells.
Inflammatory licensing is the idea that MSCs need exposure to inflammatory signals, such as IFN-gamma and TNF-alpha, to become active. Research suggests MSCs may therefore be more responsive in inflammatory conditions.
What this means for reading the evidence
Neurological research shows the same pattern. The proposed mechanism there is paracrine: potential neuroprotective signalling, immunomodulation and support of the body's own repair processes, as observed in preclinical models. Evidence suggests MSCs do not efficiently become neurons.
A plausible mechanism is not evidence of clinical benefit. Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses that clinics market.
Educational content for healthcare professionals. Not a treatment recommendation. Stem cell therapies are not FDA-approved for the orthopaedic, pain and aesthetic uses most clinics offer.
This guide covers the what and the why.
The how is taught live. The webinar and live training go deeper on:
- How the understanding of MSC mechanism developed
- How mechanism shapes study design
- Immunomodulation research across disease areas
- How the secretome relates to cell-free products
Common questions.
Do MSCs turn into new cartilage or nerve tissue?
What is the MSC secretome?
What is inflammatory licensing?
Sources
- Shi Y, Wang Y, Li Q, Liu K, Hou J, Shao C, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol. 2018;14(8):493-507.
Keep reading.
Stem cell · 3 min read
Where do MSCs come from? Tissue sources and autologous versus allogeneic cells
MSCs can be sourced from several tissues, from the patient or from a donor. The source and the processing shape both the product and how it is regulated.
Start the lessonStem cell · 3 min read
How are stem cell products quality-checked?
Cell products are checked for identity, contamination and genetic stability. This guide explains the main tests and what each one is for.
Start the lessonStem cell · 3 min read
How does the FDA regulate stem cell products? Section 361 versus Section 351
The FDA sorts cell and tissue products into two categories, Section 361 and Section 351. Culture expansion usually puts an MSC product in the stricter one.
Start the lessonReady for the hands-on detail?
Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.